Literature DB >> 8774123

Analysis of fatal pulmonary hantaviral infection in New York by reverse transcriptase in situ polymerase chain reaction.

G J Nuovo1, A Simsir, R T Steigbigel, M Kuschner.   

Abstract

The purpose of this study was to analyze the histological distribution of polymerase chain reaction (PCR)-amplified hantaviral cDNA in three cases of fatal hantaviral infection that occurred 2 years ago in Long Island, NY. The three otherwise healthy patients had a rapid death characterized by fever and pulmonary failure and were identified from the autopsy files at University Hospital, Stony Brook. Six autopsy controls with either no pulmonary disease (three) or fatal pneumonitis of known etiology (three) were also studied. PCR-amplified hantaviral cDNA was detected in the lung tissue of the three cases and none of the six controls using the reverse transcriptase in situ PCR technique. In the positive cases, viral RNA was detected in approximately 20% of pneumocytes and alveolar endothelial cells as determined with a consensus and Four Corners-specific primer pair. Infected endothelial cells were identified in a wide variety of other sites, but at rates much lower than in the lungs. The selective localization of the viral RNA in many pneumocytes and pulmonary endothelial cells using a highly sensitive PCR-based test demonstrates a correlation between direct viral infection in the lung and the disease process.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8774123      PMCID: PMC1861712     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  13 in total

1.  Typing of Hantaviruses from five continents by polymerase chain reaction.

Authors:  P Puthavathana; H W Lee; C Y Kang
Journal:  Virus Res       Date:  1992-10       Impact factor: 3.303

2.  Comparison of hantavirus isolates using a genus-reactive primer pair polymerase chain reaction.

Authors:  S Y Xiao; Y K Chu; F K Knauert; R Lofts; J M Dalrymple; J W LeDuc
Journal:  J Gen Virol       Date:  1992-03       Impact factor: 3.891

3.  Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome.

Authors:  J W Huggins; C M Hsiang; T M Cosgriff; M Y Guang; J I Smith; Z O Wu; J W LeDuc; Z M Zheng; J M Meegan; Q N Wang
Journal:  J Infect Dis       Date:  1991-12       Impact factor: 5.226

4.  Intracellular localization of polymerase chain reaction (PCR)-amplified hepatitis C cDNA.

Authors:  G J Nuovo; K Lidonnici; P MacConnell; B Lane
Journal:  Am J Surg Pathol       Date:  1993-07       Impact factor: 6.394

5.  In situ detection of polymerase chain reaction-amplified HIV-1 nucleic acids and tumor necrosis factor-alpha RNA in the central nervous system.

Authors:  G J Nuovo; F Gallery; P MacConnell; A Braun
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

6.  In situ localization of PCR-amplified human and viral cDNAs.

Authors:  G J Nuovo; G A Gorgone; P MacConnell; M Margiotta; P D Gorevic
Journal:  PCR Methods Appl       Date:  1992-11

7.  Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. The Hantavirus Study Group.

Authors:  J S Duchin; F T Koster; C J Peters; G L Simpson; B Tempest; S R Zaki; T G Ksiazek; P E Rollin; S Nichol; E T Umland
Journal:  N Engl J Med       Date:  1994-04-07       Impact factor: 91.245

8.  A novel hantavirus associated with an outbreak of fatal respiratory disease in the southwestern United States: evolutionary relationships to known hantaviruses.

Authors:  B Hjelle; S Jenison; N Torrez-Martinez; T Yamada; K Nolte; R Zumwalt; K MacInnes; G Myers
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

9.  The protean manifestations of hemorrhagic fever with renal syndrome. A retrospective review of 26 cases from Korea.

Authors:  P Bruno; L H Hassell; J Brown; W Tanner; A Lau
Journal:  Ann Intern Med       Date:  1990-09-01       Impact factor: 25.391

10.  Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease.

Authors:  S R Zaki; P W Greer; L M Coffield; C S Goldsmith; K B Nolte; K Foucar; R M Feddersen; R E Zumwalt; G L Miller; A S Khan
Journal:  Am J Pathol       Date:  1995-03       Impact factor: 4.307

View more
  5 in total

1.  Bidirectional virus secretion and nonciliated cell tropism following Andes virus infection of primary airway epithelial cell cultures.

Authors:  Regina K Rowe; Andrew Pekosz
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  Temporal and spatial analysis of Sin Nombre virus quasispecies in naturally infected rodents.

Authors:  R Feuer; J D Boone; D Netski; S P Morzunov; S C St Jeor
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

3.  Effect of Neem Leaf Extract (Azadirachta indica) on c-Myc Oncogene Expression in 4T1 Breast Cancer Cells of BALB/c Mice.

Authors:  Fauziah Othman; Gholamreza Motalleb; Sally Lam Tsuey Peng; Asmah Rahmat; Rusliza Basri; Chong Pei Pei
Journal:  Cell J       Date:  2012-06-13       Impact factor: 2.479

4.  Cytotoxic immune responses in the lungs correlate to disease severity in patients with hantavirus infection.

Authors:  J Rasmuson; J Pourazar; N Mohamed; K Lejon; M Evander; A Blomberg; C Ahlm
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-02-12       Impact factor: 3.267

5.  Infection with New York Orthohantavirus and Associated Respiratory Failure and Multiple Cerebral Complications.

Authors:  Rajeev Fernando; David Capone; Susan Elrich; Raymond Mantovani; Luther Quarles; Alison D'Amato; Nathan Lowe; Ashwin Malhotra; Teresa Khoo; Sara Zufan; Maria Morales-Betoulle; Shelley M Brown; Deborah Cannon; James C Graziano; John D Klena; Shannon Whitmer; Stuart T Nichol; Paul Strachan; Bernard C Camins; Luis A Marcos
Journal:  Emerg Infect Dis       Date:  2019-06-17       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.